Knuff & CO LLC Abbott Laboratories Transaction History

Knuff & CO LLC

$323 Million
Q3 2024

A detailed history of Knuff & CO LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Knuff & CO LLC holds 9,797 shares of ABT stock, worth $1.12 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

9,797

Previous 9,797 -0.0%

Holding current value

$1.12 Million

Previous $1.02 Million 9.63%

% of portfolio

0.35%

Previous 0.33%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$100.73 - $112.44 $37,773 - $42,165	-375 Reduced 3.69%	9,797 $1.02 Million
Q3 2023 Nov 09, 2023	SELL	$95.53 - $114.62 $19,583 - $23,497	-205 Reduced 1.98%	10,172 $985,000
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $47,870 - $53,337	-475 Reduced 4.38%	10,377 $1.13 Million
Q1 2023 May 08, 2023	BUY	$96.86 - $114.01 $60,246 - $70,914	622 Added 6.08%	10,852 $1.1 Million
Q3 2022 Nov 04, 2022	BUY	$96.76 - $112.03 $9,676 - $11,203	100 Added 0.99%	10,230 $990,000
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $17,329 - $21,219	-150 Reduced 1.46%	10,130 $1.43 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $21,158 - $24,906	200 Added 1.98%	10,280 $1.19 Million
Q1 2021 May 04, 2021	BUY	$108.84 - $128.23 $16,326 - $19,234	150 Added 1.51%	10,080 $1.21 Million
Q2 2020 Aug 07, 2020	BUY	$76.57 - $98.0 $186,065 - $238,140	2,430 Added 32.4%	9,930 $908,000
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $12,564 - $18,372	200 Added 2.74%	7,500 $592,000
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $23,553 - $26,220	300 Added 4.29%	7,300 $634,000
Q3 2019 Nov 05, 2019	BUY	$81.84 - $88.74 $12,276 - $13,311	150 Added 2.19%	7,000 $586,000
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $449,086 - $508,749	6,850 New	6,850 $495,000

Others Institutions Holding ABT

# of Institutions

3,189

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Knuff & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knuff & CO LLC with notifications on news.

Account